glp-1 jackson #414 Dr. Dwayne N. – Peptides and Agonist Drugs Masterclass GLP-1s: What They Are and

Gooen K, Grber S

It is important to consult with your doctor or healthcare provider to determine which drinks are appropriate for you while using GLP-1 medications, especially if you have specific dietary or medical considerations.

The global market for GLP-1 weight-loss medications alone was valued at around $13.84 billion in 2024 and is expected to grow at a compound annual growth rate (CAGR) of 18.54%, reaching nearly $48.84 billion by 2030

Unlike earlier GLP-1 receptor agonists, retatrutide is a triple agonist : GLP-1 receptor agonist suppresses appetite, slows gastric emptying, improves insulin sensitivity GIP receptor agonist enhances insulin release, amplifies GLP-1 effects Glucagon receptor agonist stimulates energy expenditure, fat metabolism, and potentially impacts lipid handling Clinical trials so far have shown remarkable weight loss (up to 24% in some studies) and strong metabolic improvements, including effects on lipids like LDL cholesterol

the mechanistic basis for these associations remains under investigation

Subchronic administration of d-allulose to HFD-fed mice Male C57BL/6J wild-type mice and male Glp1r KO mice fed HFD for 5 weeks or longer were orally treated with d-allulose (1 or 3 g kg 1 ) or water (10 ml kg 1 ) once daily at the onset of LP (7:30) or DP (19:30) for 9 or 10 days